Interestingly, even though Aβ and tau pathologies are still evident in scFv-h3D6-treated 3xTg-AD mice, it could be appreciated that 6E10 immunoreactivity, particularly in the subiculum, is weaker than in PBS-treated 3xTg-AD mice. The gene discussed is MAPT; the disease is Alzheimer disease.